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The Use of Different Measurement Tools Including Quantitative Ultrasonography to Assess 
Tissue Properties of Breast Cancer-Related Stage 2 Lymphedema: An Observational Study 
 
 
Stefanie Fallone  
 
Breast cancer-related lymphedema is a growing concern for patients and clinicians as it is chronic 
and leads to debilitating physical and social effects. The condition characterized by a swelling in 
the arm and hand is accompanied by numerous changes including fibrosis, adipose tissue deposits 
and fluid accumulation that are not easily detectible in clinical practice. There is no standardized 
affordable method that is used to objectively detect and assess the underlying tissue changes. 
Patients are staged based on subjective palpation and circumferential measures. The aim of this 
project was to obtain a better understanding of the muscle, fat and skin changes that occur in the 
lymphedematous limb. A total of 20 women with unilateral stage 2 breast cancer related 
lymphedema as well as 20 healthy control women were recruited to participate. They underwent 
a DXA body composition scan, a Perometer arm volume determination as well as circumferential 
arm measurements along 6 pre-determined landmarks, and handgrip strength measures. Of the 20 
patients, 7 were randomly selected to collect muscle, fat and skin strain values along the same 6 
landmarks through ultrasound elastography. This study suggested that the onset of lymphedema 
may be localized in the mid-forearm spreading proximally and raised questions regarding 
simultaneous development of lymphedematous fluid in the unaffected arm. Furthermore, results 
showed that ultrasound elastography is a tool that can be used to assess elastic tissue properties in 
a safe and time-efficient manner and can provide details on the pathology, thus helping clinicians 
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Overview of Lymphedema  
 
 
1. What is Lymphedema? 
 
 
The lymphatic system plays an important role in the immune system of the body and is 
responsible for the transportation of lymphatic fluid. Its primary functions include the drainage of 
excess interstitial fluid, the transportation of dietary lipids, and the initiation of immune 
responses against antigens. Interstitial fluid is mainly composed of blood plasma and some 
protein, and filters through the capillary walls. The excess fluid drains into the lymphatic vessels 
and becomes lymph. This excess fluid includes approximately 3 liters per day.  The lymph travels 
into the lymphatic ducts and into the internal jugular and subclavian vein as blood (Tortora et al. 
2012). Damage to the lymphatic system can consequently lead to a condition known as 
lymphedema.  
 
The initial stages of lymphedema are defined as an accumulation of protein-rich 
interstitial fluid in an area of the body, resulting from impaired lymphatic flow or damage to the 
lymphatic vessels. This can be as a result of malformation in the lymphatics, known as primary 
lymphedema, or from damage or removal of lymph nodes, such as from surgery or cancer 
treatment, known as secondary lymphedema (Cheville et al, 2003, Szuba et al, 1998).  Secondary 
lymphedema is reported as the most common form of lymphedema (Cheville et al. 2003). Several 
factors may lead to secondary lymphedema although the most common are caused by a tumor in 
the lymphatics, a tumor metastasis to the lymph nodes consequently blocking the lymphatic flow, 
or from cancer surgery or radiation therapy.  
 
There are four main types of secondary lymphedema. The first, known as iatrogenic 
lymphedema is caused by surgery or radiation therapy and can lead to fibrosis. The cause can be 
either intentional, for instance during lymph node dissection for cancer surgery, or accidental. 
Lymphedema of the arm following axillary lymph node dissection for breast cancer and 
lymphedema of the leg following pelvic lymph node dissection for pelvic neoplasms are the most 
common forms of this type of secondary lymphedema. The second, called traumatic lymphedema 
is caused from traumatic injuries. The third, is known as post-infectious lymphedema and can 
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develop as result of an infection, such as filiaris, which is caused by a parasite that is directly 
transmitted by a mosquito, and usually is present in more tropical areas. The fourth is called 
neoplastic disease and represents the involvement of tumors in the lymphatic vessels, lymph 
nodes and lymphatic ducts (Szuba et al. 1998). 
 
2. Clinical Importance of Lymphedema 
 
Breast cancer-related lymphedema occurs as a result of breast cancer treatment including 
surgery, radiation therapy and chemotherapy, and typically affects the ipsilateral upper limb. 
Patients who undergo axillary lymph node dissection as well as patients with an elevated BMI, 
particularly over 30 kg/m
2
, are at increased risk of developing the condition. Although the onset 
of the condition may occur any time following the cancer treatment, the majority of patients will 
begin to experience symptoms of lymphedema within the first 2-3 years after breast cancer 
treatment.  However, some patients develop the condition as early as 30 days following their 
cancer treatment, and as late as 30 years after. It has been reported that lymphedema affects over 
90 million people worldwide (Garza et al. 2017, Park et al. 2007), and that lymphedema 
following breast cancer will develop in about 1 in 8 Canadian women (Canadian Cancer Society, 
2019). This chronic condition, although not life-threatening, is followed by multiple debilitating 
complications and a negative impact on the patient’s quality of life. Symptoms are described as 
swelling, feelings of tightness and heaviness, weakness, pain, and tension. Furthermore, it causes 
feelings of anxiety, social isolation and stress (Tassenoy et al. 2016). The condition also puts 
patients at high risk of cellulitis, and results in frequent hospital visits (Moffatt et al. 2003). 
 
3. Staging of Lymphedema 
 
The diagnosis of lymphedema is based mainly on changes in limb volume. Ideally, one 
would want to detect the condition as early as possible, as early detection and treatment may lead 
to reversibility.  However, there currently exists no technique that can identify very early limb 
volume or subcutaneous tissue changes, nor is there any tool that can identify patients that may 
be predisposed to this chronic condition that requires continuous self-management and treatment 
(Dixon et al. 2015).  

 5	
in the limb especially at the end of the day, along with a feeling of heaviness. Pitting edema is 
also present; however, it disappears with elevation or overnight. At this stage, the disease may 
still be reversible, as the swelling is characterized by an accumulation of lymph fluid that can be 
drained by combined decongestive physiotherapy (for example, manual lymphatic drainage 
techniques, compressive bandaging, elastic sleeves). It is usually during the latter part of Stage 1 
and most often in Stage 2 that lymphedema is usually diagnosed. Therefore, the majority of 
patients fall under Stage 2 and remain at that stage if the disease is properly controlled. Stage 2 is 
the stage that involves multiple subcutaneous tissue changes, including the beginning of fibrosis, 
an accumulation of adipose tissue deposits, a hardening of the tissue and non-pitting edema.  
These changes are now mostly irreversible and one can only hope to prevent further deterioration. 
In Stage 3 we begin to see skin thickening (pachydermia), changes in dermal papillae and 
inflammatory skin changes (dermatitis and hyperpigmentation). Although it is rare for patients to 
progress to the late Stage 3, this stage is defined as the most advanced stage of swelling and is 
called elephantiasis (Dixon et al. 2015). In this stage, the skin changes in shape and form and the 
extremities of the limb begin to resemble the legs of an elephant (Garza et al. 2017). This stage is 
also categorized by the absence of pitting, further fat deposition, fibrosis, and the development of 
wart-like nodules (Hoffner et al. 2017). 
 
 Given that the condition becomes irreversible at the onset of stage 2, and that this stage 
involves multiple subcutaneous changes, it is essential to have a technique that can objectively 
quantify these changes along with accurate limb volume measurements at this early stage. This 
would then allow for treatment early in the course of the disease and thus potentially improve 
long term patient outcomes.   
 
Techniques to Monitor Lymphedema 
 
1. Tools to Measure Volume 
 
Typically, lymphedema diagnosis and monitoring is limited to the identification of 
changes in the limb shape and size. These mainly involve indirectly calculating the volume of the 
limb and comparing it to the unaffected limb, as well as monitoring change of volume over time. 




Apart from tape measurement, other techniques have been developed to measure the 
volume of a limb. One common technique for lymphedema volume measurement is perometry: a 
3D scanning technique that measures the volume of a limb using 360 degrees of infra-red light 
(Dixon et al. 2015).  The tool consists of a square-measuring frame that moves along the long 
axis of the limb being measured (Hwang et al. 2014). The machine measures the surface area of 
the limb at 0.5 cm increments, from which volume is calculated. Although the measurement is 
time efficient, the machine is rather large and expensive (Garza et al. 2017). An image of the 
perometer device along with the software application and image output is illustrated on figure 3.  
 
The main issue with this technique is that when measuring the volume of the limb, it 
omits the extremities, such that any swelling in a hand, for instance will not be taken into 
consideration. This can lead to the possibility of under-diagnosing the disease. Under certain 
circumstances, tape measurements have been shown to diagnose lymphedema at a higher 
sensitivity than perometry (Armer et al. 2009). Both techniques; however, are limited in their 











scale on the elastogram, the elastography software calculates the strain ratio between the 
reference area and the diseased area. (Brandenburg et al. 2014).     
  
A summary identifying the advantages, disadvantages and applicability of the different 
lymphedema measuring techniques mentioned above can be found in Table 2. 
 
TABLE 2: Summary of the techniques used to diagnose and monitor lymphedema (This table 
was generated from data presented in the following references: Dixon et al. 2015; Garza et al. 
2017; Szuba et al. 1998; Newman et al. 2013; Righetti et al. 2007, Semelka, 2007) 
 
Technique  Cost Time-efficiency Safety Reliability and 
applicability  
Measurement 
Tape Measure Very low  Time-intensive Safe  Susceptible to poor 
inter-observer 






Perometry  Moderate Quick  Safe  Accurate but lacks 
information on distal 





Low  Quick   Safe  Gold Standard, but 
may be subject to 
challenges with inter-
rater and intra-rate 
reliability. 
Volume  
BIS Low Quick Safe  Can detect early 
changes of 
inflammation, no 
information on tissue 
structure, portable 
Extracellular 
fluid content, lean 
mass and fat mass 
measures for 
stage II patients 
DXA Expensive  Quick  Safe 
(minimal x-
ray) 
Has been shown to 
provide acceptable 
precision in measuring 
Measurement of 
lean mass, fat 
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the body composition, 
but more useful in 
unilateral lymphedema  
mass and bone 
mineral mass 




tissue and water 
visualization  
CT Very Expensive  Moderate Exposure to 
radiation 














 Another tool that is often used to assess breast cancer survivors and could be used with 
lymphedema patients is the handgrip dynamometer. This tool is an indicator of muscle capacity 
and provides a measure of forearm muscle strength which can be used to assess changes in 
muscle function as a result of lymphedema. In fact, it has been shown that changes in handgrip 
and body composition can occur six months after breast cancer surgery (Gomes eta. 2014).  
 
 
Ultrasound and Body Composition 
 
Some of the first literature that evaluated the use of ultrasonography as a measure of body 
composition was conducted by Ikai et al (1968). Ultrasound has been widely used since then as a 
measure of body composition. For example, in a study conducted by Young et al (1980), 
ultrasonography was used to assess the severity of quadriceps muscle wasting following an injury 
and immobilization of the leg and was compared to the standard measure of circumference tape 
measurement. The authors assessed the knees of 21 participants (5 females and 16 males). They 
took bilateral ultrasound scans of each participant’s knee at a frequency of 2.5 MHz. The authors 
 17
compared the difference in muscle wasting between the uninjured and injured leg and also tested 
the reproducibility of the results by re-assessing the thighs of seven subjects at four different 
occasions. The authors concluded that assessing the composition of the thigh through ultrasound 
revealed more severe muscle wasting than through the tape measurement. The authors described 
that anthropometric measures overestimate the size of the muscle since a layer of subcutaneous 
fat surrounds it, but ultrasonography can provide an image that distinguishes the muscle from the 
fat.  
  
 It is interesting to note that over thirty years ago, the literature identified the lack of 
validity in using a tape measure as an assessment tool for body composition, yet this is still the 
most common method for monitoring lymphedema. Young et al (1980) did however describe 
certain limitations regarding the use of ultrasound in their study, such as issues when scanning 
very lean thighs due to the difficulty to apply a stable compression with the transducer causing 
the outer border of the muscle to be hidden, and the method being time-consuming. Nevertheless, 
there have since been multiple advancements in this technique.  In fact, in a study conducted by 
Minetto et al. (2015), 44 older adults with a mean age of 82 + 7 years and 60 younger individuals 
with a mean age of 26 + 3 years were assessed by bioelectric impedance and ultrasonography in 
order to establish muscle specific and population specific cut-off values for low muscle mass. 
Three consecutive B-mode static ultrasound scans of lower body muscles were taken by the same 
evaluator.  The authors assessed the intersession and intra-rater reliability of the ultrasound 
measures by determining the intraclass correlations and coefficients of variations of the three 
scans for each muscle being assessed. The authors obtained the following correlations and 
coefficients of variations for the rectus femoris muscle, the vastus lateralis, the tibialis anterior, 
and medial gastrocnemius respectively: 0.98 and 3.2%, 0.99 and 3.3%, 0.98 and 1.5%, 0.97 and 
3.7%. Ultrasound was suggested to be a highly sensitive tool for the assessment of low muscle 
mass. The authors therefore suggested using ultrasound to identify site-specific cut-off points for 
sarcopenia diagnosis. They also showed that the bioelectric impedance derived criteria and cut-
off points underestimate the prevalence of low muscle mass, as it ranged from 2 to 75% 
depending on the diagnostic criteria being used and therefore concluded that ultrasound would be 
the modality of choice.  
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 Recent studies have also used ultrasound as a tool to investigate muscle architecture. In 
fact, Rastelli et al. (2015) assessed the muscle architecture of the muscle bellies of the quadriceps 
femoris. Specifically, the authors measured muscle fascicle length and pennation angle of the 
muscles of five obese women and six normal weight women in order to determine if changes in 
muscle composition from fat infiltration and changes in muscle architecture from reduced 
fascicle length or increased pennation angle were associated with less force production regardless 
of increased muscle cross-sectional area in obese women. Ultrasound images of the quadriceps 
were obtained by moving the transducer probe along the muscle bellies. The operator would then 
identify the proximal and distal edge of each muscle of the quadriceps and divided the length into 
three landmarks. Images were taken for each of those landmarks. The pennation angle was 
determined as the angle between the muscle fascicular paths and their insertion in the deep 
aponeurosis.  Four different fascicles were measured in each image and the average value was 
analyzed. The ultrasound images found the pennation angle of obese women to be significantly 
greater than the normal weight women, concluding that steeper pennation angle has a negative 
effect on muscle performance. Abe et al. (2016) also used ultrasound to investigate muscle 
quality. The authors tested the relationships between age-related declines in muscle strength, as 
measured by a handgrip dynamometer, and loss of muscle thickness and muscle forearm quality 
through ultrasound and suggested that age-related decline in handgrip strength is associated with 
muscle quality. The authors described ultrasound as a portable alternative to DXA to estimate 
muscle quality of the forearm.  
 
Ultrasound and Lymphedema  
 
The use of ultrasound has recently begun to gain interest in the assessment of 
lymphedema. Many studies have used ultrasonography as a tool that can predict or monitor 
treatment outcomes in lymphedema patients. In fact, in a study conducted by Niimi et al (2014), 
178 outpatients and 29 inpatients with unilateral leg lymphedema following cancer were studied 
in order to test whether fluid accumulation as visualized through ultrasound can be a predictor of 
the patient’s response to compression physical therapy. Ultrasound images were taken at three 
different time periods including at the onset of their therapy, at one month and at two months. 
The ultrasound measures were taken from linear 7.5 MHz to 10 MHz probes and fluid 
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Hacard et al. (2013) also assessed the effectiveness of treatment outcomes through 
ultrasound. They evaluated thirty patients with lymphedema undergoing a five-day intensive 
decongestive treatment. The authors took the circumferential measurements of the affected limb 
and correlated it to the dermal thickness of the skin as measured through ultrasound. The authors 
also assessed the biomechanical properties of the skin using a Cutometer and the quality of life of 
the patients using a visual analogue scale.  The ultrasound scans were taken at 15 frames per 
second 15mm wide and 7 mm deep. Images were taken at three locations on the limb: 15 cm 
above and below the elbow and at the top of the hand for an individual affected with upper limb 
lymphedema and 20 cm above and below the knee and at the top of the foot for individuals with 
leg lymphedema. Dermal thickness was measured from the surface of skin down to the deepest 
point of dermal echogenicity. Measurements were taken before the physiotherapy treatment and 6 
months later. Reductions in skin thickness as a result of the physiotherapy were observed. 
Spearman coefficient correlations between the relative changes in volume and changes in dermal 
thickness were found to be statistically significant (r=0.37, p=0.02), meaning that ultrasound 
determines that treatment reduced lymphedema by a reduction in dermal thickness. Interestingly, 
none of the parameters correlated with quality of life improvement following the treatment. 
 
Suehiro et al. (2015) used ultrasonography of subcutaneous tissue in order to test the 
effectiveness of physiotherapy treatment on leg lymphedema outcomes. The authors describe that 
the current outcome measurement tool for lymphedema monitoring is through volumetric volume 
measurements but that circumferential measurements alone are not enough to understand the 
nature of extremity volume changes in lymphedema patients. For example, a limb enlargement 
can be due to tissue fluid accumulation just as it can be due to tissue proliferation. The authors 
therefore identified the need for a tool to monitor treatment results using tissue echogenicity 
assessments of lower limbs with lymphedema. They defined tissue echogenicity as inflammatory 
tissue changes, and the subcutaneous echo-free space as fluid accumulation between the 
superficial fasciae. The criteria used to define both echogenicity and echo-free space are 






The authors described ultrasound as a useful examination tool for patients with lymphedema of 
the arm following breast cancer.  
 
 
Project Overview  
 
Breast cancer-related lymphedema is a chronic condition that leads to multiple physical 
and psychosocial complications in the patient’s life. Stage 2 lymphedema is the stage in which 
there are the most dynamic tissue changes in the affected arm. These changes can include a 
hardening of the tissue, fibrosis, and non-pitting edema (Dixon et al. 2015). However there exists 
no standardized criteria to diagnose, stage and monitor the condition. Presently the most common 
ways of assessing the condition in clinical practice is through subjective measures, such as 
palpation, pitting tests, and circumferential arm measures. The main issue with this is that it does 
not provide any descriptions nor information of the changes in the underlying tissue of the arm. 
Furthermore, circumference measurements can lead to errors when marking the landmarks on the 
limb and applying an inadequate amount of tension on the tape and can therefore lead to 
problems with precision. There is currently a large gap in the literature involving the use of 
objective measurement techniques in lymphedema patients. To our knowledge there are no 
published findings on the changes in lymphedema through objective measurement tools such as 
ultrasound by comparing a cohort of patients affected with the condition to a cohort of healthy 
controls. There also seem to be no such findings comparing the affected arms of unilateral 
lymphedema patients with the unaffected healthy limb.  
 
The purpose of this thesis project was to obtain a better understanding of the tissue 
changes in arm lymphedema following breast cancer treatment. Specifically, with the use of 
several lymphedema measurement techniques, lymphedema in breast cancer patients was 
extensively characterized and compared to normal controls. The project was divided into two 
parts; The first part (Chapter II) consisted of obtaining an overall understanding of the pathology 
by comparing a group of women diagnosed with lymphedema to a group of healthy controls. 
Comparisons were done using the currently most common methods to assess the condition, that is 
circumferential tape volumetric measurements, Perometry, DXA as well as an assessment of 
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handgrip strength. The primary aim of this study was to assess the arm fat and arm lean tissue of 
the arm affected with lymphedema and to compare it to the unaffected side, as well as to look at 
differences in arm volume, segmental arm circumferences, and forearm muscle strength. The 
secondary aim of this study was to assess the correlation between lean tissue and forearm muscle 
strength. This study had the following hypotheses: 1) We hypothesize that the arm affected with 
lymphedema will have significantly more lean mass and fat mass compared to the unaffected side 
as well as significantly higher volume and arm circumference measurements along the arm 
affected with lymphedema. 2) We hypothesize no significant difference in these measurements 
between the right and left arms of the control women. 3) We hypothesize a strong correlation in 
lean mass and handgrip strength in both groups.  
 
The second part of the study (chapters III and IV) include an assessment of the 
lymphedematous limb through a novel ultrasonic technique called ultrasound elastography to 
obtain measurements of fat, skin and muscle tissue. The aim was to assess the tissue 
characteristics, including the tissue compliance of the arms of women with lymphedema. 
Comparisons were made to the opposing unaffected limb of these women. Our hypothesis is the 
following, we foresee as significant difference in fat strain, muscle strain and skin strain between 
both arms of women with lymphedema, where the arm affected with lymphedema will have 
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Background: Breast cancer is one of the commonest cancers in women. With modern 
treatments, the survival rates are increasing. Breast cancer-related lymphedema (BCRL) is a 
condition defined as swelling in the upper extremity due to damage to the lymphatic transport 
system from breast cancer surgery or radiation therapy. This condition is characterized by an 
accumulation of fluid and adipose tissue deposits followed by various tissue changes including 
fibrosis. In clinical practices, the most common tools used to assess the progression of the 
condition include arm circumferential measurements, and palpation. These methods are 
subjective and fail to provide any detail of muscular or fat or tissue changes that occur 
underneath the skin. The aim of this study was to obtain a better understanding of arm tissue 
composition following lymphedema diagnosis.  Methods: A total of 20 women diagnosed with 
unilateral breast cancer-related Stage 2 lymphedema and 21 healthy controls underwent a series 
of tests including assessments of lean and fat tissue through a DXA scan, a volume measurement 
of the arms through a Perometer, circumferential measurements at 6 spots along the arms and 
assessments of forearm strength through a handgrip dynamometer.  Paired t-tests were used to 
compare differences between the affected lymphedema arm and the unaffected side in the patient 
group and between the left and right arms of the control group. Results: The affected arm was 
found to be significantly larger in volume compared to the unaffected side (3613mL + 909 vs. 
3161 mL + 939, p=0.01). There was a 12.9% (95%CI: 6.2-19.6%) larger fat mass and 13% 
(95%CI: 6.2-19.8%) larger lean mass in the affected limb compared to the opposite limb. Arm 
circumference ratios of the affected over unaffected arms were larger around the mid-forearm 
region as compared the more proximal or distal regions of the arm (1.134 + 0.149 vs. 1.018 + 
0.062, p<0.01). There was no correlation between handgrip and lean mass in the lymphedema 
arm (r=-0.03, p=0.87, n=19). Conclusion: This study suggests that lymphedema is most 
important around the mid-forearm area according to volume measurements, and that lymphedema 
may be spreading towards from the affected to the unaffected side since there was no correlation 
between lean mass as measured by DXA and handgrip strength in the both arms of women 
lymphedema. The increased lean mass measured by DXA may simply have been due to a false 






With an increasing number of breast cancer survivors, more women are developing 
lymphedema. In fact, worldwide there are over 1.38 million new cases of breast cancer every 
year (WHO, 2015) of whom slightly over 20%, or one in 5, will develop arm lymphedema. This 
estimates to 286,000 women (DiSipio et al. 2013) yearly with new onset of lymphedema. 
Lymphedema is a chronic condition that causes multiple physical and psychological issues for 
the patient, such as pain, heaviness, tightness, decreased range of motion, impaired daily 
function, and impeded social relationships (Hayes et al. 2012). In a study by Roses et al. (1999), 
arm lymphedema was found to represent a constant reminder of the cancer. Maunsell et al. (1993) 
also demonstrated that lymphedema contributed to anxiety and depression.   Furthermore, the 
lymphedema can compromise tissue oxygenation and the immune system. This puts patients at a 
high risk of bacterial cellulitis and recurrent episodes of infections (Tassenoy et al. 2009), and 
higher mortality (Hayes et al., 2011). In a survey by Moffatt et al. (2003), approximately 30% of 
patients with lymphedema had been admitted to hospital in the previous year for intravenous 
antibiotics due to infections. The authors also reported that over 80% of lymphedema patients 
had to take time off work. 
 
Currently, there is a lack of standardized criteria for detecting lymphedema following 
breast cancer. There are significant differences in study design, diagnostic methods and timing of 
lymphedema measurement with respect to breast cancer treatment. As such, no consensus exists 
on when and how to search for this condition. Apart from the absence of diagnostic criteria, there 
also remains limited knowledge on the pathology and natural progression of the disease, and 
there is no objective quantitative method of staging the disease nor diagnosing it early enough to 
allow for prevention, early treatment and possible reversibility of the condition (Dixon et al. 
2015).  The large gaps in the understanding and in the diagnosis of lymphedema are mainly due 
to a lack of objective measurement techniques. 
 
The primary aim of this study was to compare the tissue composition changes in patients 
who have been diagnosed with breast cancer-related lymphedema (BCRL) using DXA, 
Perometer, a circumference tape measurements, and handgrip dynamometer to a group of healthy 
control women. The secondary aim of this study was to assess the correlation of lean tissue 
 28
measurements to both forearm strength and volume measurements of women with BCRL and 






For this study, we chose to include a total of 40 women separated into two groups: our 
experimental group which consisted of women diagnosed with breast cancer-related lymphedema 
and a healthy control group. We chose to recruit a total of 40 women for this study as this is a 
new area of research in which the main purpose was to provide pilot data.  This study was a 
cross-sectional, observational study comparing the affected and unaffected arms of 20 patients 
diagnosed with stage 2 lymphedema. In addition, 20 healthy “controls” matched for BMI 
underwent the same battery of tests and assessments. The inclusion and exclusion criteria to 




The inclusion criteria for our experimental group consisted of women diagnosed with stage 2 
unilateral lymphedema following breast cancer treatment. Patients that demonstrated the 
following criteria were approached to participate in this study: 
• Above the age of 18 years 
• BMI of 25 or over 
• Diagnosis of unilateral stage 2 lymphedema of the arm 
• Fluent in English or French, or accompanied by someone who is fluent in English or 
French 
We chose to include a BMI of 25 or over, as a higher BMI is an increased risk factor for 






Control Group:  
The inclusion criteria for the control group consisted of healthy women with no diagnosis of 
lymphedema. Women displaying the following criteria were approached to participate in this 
study:  
• Above the age of 18 years-old 
• BMI of 25 or over 




 The following exclusion criteria were applied to both groups:  
• Diagnosis of recurrent cancer  
• Currently under treatment for breast cancer 
• Bilateral lymphedema of the arms  
• Any diagnosis of the following diseases: heart, liver, or kidney disease 
 
Our Control women were recruited from the Concordia University staff, the Montreal 
community and the McGill University Health Centre (MUHC) Cedars Breast Centre, through 
word of mouth by approaching colleagues, friends and women accompanying patients to their 
appointments. The experimental group was mainly recruited from the MUHC Lymphedema 
Program and the MUHC Cedars Breast Centre. A total of 41 women agreed to participate in this 
study; 20 women met criteria for the experimental group and the remaining 21 met the criteria in 




All procedures were carried out at the McGill Nutrition and Performance Laboratory 
(MNUPAL). Procedures and assessments were explained and informed consent was obtained. 
Participants’ age, date of birth and medical history were recorded, followed by the measurement 
of their height and weight from which BMI was then calculated. The weight scale used was the 
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Detecto Scale Model 750 (+/- 0.1 kg). The height scale used was the Seca Wall Mounted height 
scale (+/-0. 1 cm). 
 
  Participants then underwent two DXA measures using the Lunar Prodigy Advance 
hardware (December 2005) and the Encore 2006 v.10.50.086 software. The first consisted of a 
full body scan, where patients were instructed to lie supine with bodies aligned within the four 
quadrants of the machine. Patient’s arms were placed by their side with their hands stacked and 
fingers together. All jewelry was removed for the scan. The scan took a total of 6 minutes.  The 
second scan consisted of the right and left femoral hip. Patients were again instructed to lay 
supine properly centered within the four quadrants of the machine. Patients’ hips were internally 
rotated for this scan and the feet were strapped along the triangular contraption to ensure the hips 
remained in proper position for the scan. This data was taken to assess the incidence of 
osteoporosis and will be used for future research studies.  
 
Following the DXA scan, patient underwent volumetric measurements with the Pero-
System Type 350 NT (Peroplus 2000 built 2014.01h). The Perometer was used once on each arm. 
Patients were asked to sit with their legs uncrossed, with their feet flat on the floor with the knees 
flexed at a 90-degree angle. The Perometer was then adjusted accordingly to the patient’s height 
such that their arm was abducted to 90 degrees with the palm facing down and with the tip of the 
middle finger resting on the appropriate location of the machine. The machine was then moved 
along the length of the patient’s arm to obtain a volume measure of the entire arm.  
 
The next step included the arm circumference measurements. Patients were instructed to 
sit comfortably on a chair with their back rested and their arms in a supinated position on their 
thighs. Measurements were taken with a 100-cm cloth tape measure (+/- 0.1 cm) and recorded in 
centimeters. A total of 6 circumference measurements were taken on each arm, at the following 
landmarks:  
1- The palm, in line with the web space of the thumb 
2- The wrist 
3- 10 cm above the wrist landmark 
4- The crease of the elbow  
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5- 10 cm above the elbow landmark 
6- At the highest point in the arm, in line with the axilla and at the midline of the deltoid 
 
These landmarks are illustrated in figure 1 and have been shown to provide inter-rater 
reliability (Khan, 2014).  
 
FIGURE 1: Circumference tape landmarks marking the arm segments. The numbers on 
the figure represent the landmarks indicated in the text  
 
The research assistant was seated in front of the participant and measured the circumference of 
the arm by placing the tape around the landmark. Tension was applied on one end of the tape and 
the measurement was recorded to the nearest 0.1 cm. The six landmark measurements were first 
taken from the affected arm (experimental group) and repeated on the unaffected arm.  
 
 The last step in the assessment was the handgrip strength measurement to assess the 
subject’s strength generated from the muscles of the hand, forearm, and upper arm. The subjects 
were seated with their back rested and the forearm flexed at a 90-degree angle at the elbow 
placed on the chair’s arm rest. Subjects were asked to squeeze the handgrip dynamometer (Jamar 
Hydraulic Hand Dynamometer +/- 0.1 kg) as hard as they could for a total of 2 seconds. The 
handgrip test was repeated twice, on both arms alternating arms between measurements with a 10 




3. Statistical Analyses  
 
Demographic data was compared between both groups using mean + standard deviation 
and independent t-tests. Within-group comparisons were completed using paired t-tests. 
Comparisons in Perometer, HGS, and DXA fat and lean measures were done between both arms 
in the control and the experimental groups using paired t-tests. Ninety five percent confidence 
intervals were used to assess body composition ratios in the control group and in the 
experimental group. A series of One-Way Analysis of Variance and Post-hoc Tukey tests were 
also used to compare the differences in arm circumferences in both arms in both groups. Pearson 
product moment correlations were used to assess the following relationships: lean mass and 
Perometer arm volume measurements, and handgrip strength and lean mass.  
 
4. Ethics and Funding 
 
This study obtained ethics approval from both the McGill University Health Centre and 
from Concordia University. Funding was obtained from the Dr. Louis G. Johnson Foundation and 




The results in this study are presented in 4 parts:  
 
1. Demographic and Body Composition Data 
 
Of the 41 participants in this study, 20 had been diagnosed with stage 2 breast cancer-
related lymphedema. One of the women in the experimental group refused to undergo the DXA 
scan. She was therefore excluded in the assessment of DXA measurements.  
 
A comparison between both groups is presented in table 1.	Independent t-tests were used 
to compare the means in age, height, weight, BMI, percent body fat, total fat, total lean and BMD 
amongst both the experimental and the control group. A P value smaller than 0.05 was 
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considered significant. Handedness was recorded in all participants, except for one in the 
experimental group that was missed. This was defined by asking the participant “which hand do 
you write with?”. The side affected with lymphedema was also recorded.  
 
TABLE 1: Demographic and body composition data (mean + standard deviation) between 
women diagnosed stage 2 breast cancer related lymphedema compared to women without 
lymphedema.  
	





Age  56 + 14.8 48 + 20.8 0.184 
Height (m) 1.62 + 0.07 1.59 +0.06 0.198 
Weight (kg) 84.6 + 18.4 73.9 + 11.1 0.03* 
BMI (kg/m2) 32.1 + 7.2 29.0 + 4.2 0.101 
Body Fat (%) 47.5 + 6.9 42.4 + 6.4 0.023* 
Total Fat (kg)  39.1 + 13.1 30.5 + 8.1 0.021* 
Total Lean (kg) 41.6 + 5.8 40.1 + 4.5 0.363 
BMD (g/cm
2
) -0.673 + 1.077 -0.110 + 1.411 0.200 
Right Handed (%) 84 100 - 
Lymphedematous 
limb is on the 
dominant side (%) 
47 NA - 
 
2. Measurement Comparisons  
 
Paired t-tests were used to compare the handgrip strength measurements, Perometer 
volume measures of the arm, arm fat measures obtained from DXA as well as arm lean measures 
obtained from DXA between one and the other arm in both the experimental and the control 
groups. In the experimental group, the affected arm was compared to the unaffected arm whereas 
the dominant (right) arm was compared to the non-dominant (left) arm in the control group. 
 
Handgrip Strength:   
 
There was no significant difference in handgrip strength between the dominant (right) and 
non-dominant (left) arms of the control group participants (23.8kg + 7.2 vs 23.3kg + 5.8, 
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p=0.755). There was also no significant difference between the affected and unaffected arms in 
the group with BCRL (22.9kg + 7.7 vs. 24.2kg + 5.1, p=0.414).	Handedness did not affect the 
significance of these results (p=0.837 when the affected arm was dominant, p=0.111 when the 
affected arm was non-dominant). 
	
Arm Volume:  
  
There was no significant difference in the Perometer-measured volume of the dominant 
(right) arm compared to the volume of the non-dominant (left) arm in the control group women 
(3420mL + 990 vs 3355 mL 914, p= 0.738). There was; however, a significant difference found 
between the affected and unaffected arms in the BCRL group, with the affected arm having a 
significantly larger volume compared to the unaffected arm (3613mL + 909 vs. 3161 mL + 939, 
p=0.010). The trend was persistent when controlling for handedness, as is shown in table 2. The 
decrease in the significance of the p value is explained by the decrease in the number of subjects 
when considering handedness.  
 
TABLE 2: Volumes of the affected and unaffected arms of women with lymphedema  
 
 Mean volume 
of the affected 
arm (mL) 
Mean volume of the 
unaffected arm (mL) 
n P value 
Women with 
lymphedema 
3613 3161 20 0.010 
Lymphedematous 
limb was the 
dominant limb 
3811 3220 9 0.078 
Lymphedematous 
limb was the non-
dominant limb 




Arm Fat and Arm Lean Measurements:  
 
Measurements of arm fat and arm lean were extracted from the DXA scans. For the 
control group, we found no significant differences between the dominant (right) and non-
dominant (left) arms for both arm fat and arm lean measures. There was; however, a trend that 
was identified. In fact, results demonstrated that the right arm had more fat (1.267kg + 0.374 vs 
1.223kg + 0.77, p=0.066) and more lean tissue mass compared to the left arm (1.863kg + 0.294 
vs 1.799+ 0.3320, p=0.057).  
 
In the BCRL group, there were no significant differences in arm fat (1.863 + 0.624 vs 
1.917 + 1.363, p=0.834), nor arm lean (2.160 + 0.558 vs. 1.971 + 0.507, p=0.253) measurements 
between the affected and unaffected arms. When taking handedness in consideration, we found a 
significant difference in these measurements, but only when the affected arm was not 
corresponding to the dominant limb. In fact, the lymphedema limb was found to have more fat 
and more lean tissue when compared to the unaffected side. The significance was not seen when 
the affected arm was the dominant limb, as shown on table 3.  
 
TABLE 3: (A) DXA fat measures and (B) DXA lean measures on the affected and unaffected 
arms of women with lymphedema 
A Mean arm fat in 
the affected arm 
(Kg) 
Mean arm fat in 
the unaffected arm 
(Kg) 
n P value 
Women with Lymphedema 1.863 1.917 20 0.834 
Lymphedematous limb is the 
dominant limb 
1.785 2.157 9 0.500 
Lymphedematous limb is the 
non-dominant limb 
1.870 1.624 10 0.038 
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B Mean arm lean in 
the affected arm 
(Kg) 
Mean arm lean in 
the unaffected arm 
(Kg) 
n P value  
Women with Lymphedema 2.160 1.971 20 0.253 
Lymphedematous limb is the 
dominant limb 
2.139 2.051 9 0.796 
Lymphedematous limb is the 
non-dominant limb 
2.126 1.829 10 0.026 
 
Body Composition Ratios:  
 
Confidence intervals were computed to compare the body composition obtained from the 
DXA measurements between the dominant (right) and non-dominant (left) arms of the control 
women as well as the affected and unaffected arms of the women diagnosed BCRL. A boxplot 
statistic was used to omit the outliers. See table 4 for a summary of these results. Using 95% 
confidence intervals, all the differences achieved statistical significance with or without exclusion 
of outliers. For the control women, results showed both 3.9% (95%CI: 0.2-7.5%) more fat and 
3.9% (95%CI: 0.2-7.5%) more lean tissue in the dominant (right) arm compared to the non-
dominant (left) arm. For the BCRL group, despite no difference being detected in absolute arm 
fat and arm lean measurements, the body fat composition was 12.9% (95%CI: 6.2-19.6%) larger 
in the affected limb compared to the opposite limb. Lean composition was also 13% (95%CI: 
6.2-19.8%) larger in the affected limb.  
 
TABLE 4: Body composition ratios between the dominant and non-dominant arm of the control 
group and the affected and unaffected arms of the BCRL group.  
 Control n=21 
(dominant/non-
dominant)  
95%CI BCRL (outliers omitted) 
(affected/unaffected) 
95%CI 
Arm Fat 1.039  1.002, 1.075 1.129  1.062, 1.196 
Arm Lean 1.039  1.002, 1.075 1.130  1.062, 1.198 
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A one-way ANOVA was also used to compare arm composition (lean and fat) by using 
the ratio of the dominant over non-dominant arm of the control women, and the ratio between the 
affected to unaffected arms of women with BCRL. A significant difference was found between 
the control and the BCRL groups [F(3, 68)=4.87, p=0.004)].  
 
A post hoc Tukey test was used to identify the differences amongst the ratios. The two 
ratios for fat tissue (1.13 + 0.121) and lean tissue (1.13 + 0.123) for the group diagnosed with 
BCRL was found to be different then the two ratios for fat (1.039 + 0.08) and lean tissue (1.039 + 
0.08) of the control group (p<0.05), showing that the difference in fat and lean composition 
between arms of the lymphedema patients was significantly larger than in the control group.  
 
Circumference Measurements  
 
Differences in arm circumference measurements were assessed in 6 different locations 
along the arm in order to verify if the lymphedema was spread uniformly along the arm or 
regionally affected. We chose to only look at circumference rather than indirectly compute the 
volume as this would serve as a more practical and efficient technique in a clinical setting. A 
One-Way Analysis of Variance showed significant differences along the arms of the control 
group [F(5, 120)=3.0770, p=0.012) and along the arms of the women with BCRL 
[F(5/114)=3.6751, p=0.004).  Tukey-Kramer Multiple comparison test was used to identify the 
locations of these differences. For the control women, the following circumference ratio (right 
arm/left arm) differences were noted: location 1 (palm) was found to be statistically larger from 
location 5 (mid arm) and location 6 (below shoulder), but locations 5 and 6 were not different 
from each other, as illustrated on figure 2a.  For the women diagnosed with lymphedema, the 
following circumference ratio (affected/unaffected) were noted: location 3 (mid-forearm) with a 
mean ratio of 1.134 + 0.149 was found to be statistically larger than locations 1 and locations 6, 
as shown on figure 2b. Location 1 was found to have the lowest arm circumference ratio with a 
mean ratio of 1.018 + 0.063. Location 1 and location 6 were both shown to be different than 
location 3, but were not different to each other.  Hence the bulk of the increase in size in the 
lymphedematous arm was in location 3 (mid forearm).  
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FIGURE 2: Chart illustrating the arm circumference ratio of dominant over non-dominant arm 
in the healthy control women across the 6 locations along the limb and the ratio of the affected 





The locations that were predominately altered by the lymphedema were not affected by 
whether the lymphedematous limb was the dominant arm. When the dominant arm was also the 
affected arm, there was a slightly larger arm circumference across the 6 locations as compared to 
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Pearson correlations were used to determine whether lean mass correlated with either 
handgrip strength or arm volume, both in the control group and the experimental group. The 
following correlations were calculated:  
 
Handgrip strength vs. Lean tissue 
 
For the control group, there was a strong correlation between the hand grip strength on the 
left arm and the lean mass on the left arm (r=0.868, p=0.000001, n=19) and there was a moderate 
to strong relationship between the handgrip strength of the right arm and the lean mass on the 
right arm (r=0.667, p=0.0018, n=19) 
 
For the women with BCRL, there was no linear correlation between the handgrip strength 
in the unaffected arm and the lean mass in the unaffected arm (r=0.087, p=0.722, n=19). There 
was also no linear correlation between the handgrip strength of the affected lymphedema arm and 
the lean mass in the affected arm (r=- 0.03, p=0.87, n=19). 
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Lean tissue vs. Arm Volume  
 
For the control group, there was a moderate to strong correlation between the lean mass 
on the right arm and the volume of the right arm (r=0.7, p=0.0008, n=19), as well as between the 
lean mass on the left arm and the volume of the left arm (r=0.71, p=0.0006, n=19). We also found 
a moderate to strong correlation between the measurement of the sum of the fat and lean tissue in 
the right arm and the volume of the right arm (r=0.7246, p=0.00017, n=19). A similar correlation 
was found between the sum of the fat and lean tissue in the left arm and the volume of the left 
arm (r=0.732, p=0.00016, n=21). 
	
For the women with BCRL, there was a moderate to strong correlation between the sum 
of fat and lean tissue in the affected arm and the volume measure of the affected arm (r=0.675, 
p=0.002, n=18). There was a strong correlation between the sum of fat and lean tissue mass in the 
unaffected arm and the volume measurement of the unaffected arm (r=0.86, p=0.00001, n=18). 
There was a moderate correlation between the lean mass in the affected arm and the volume 
measure in the affected arm (r=0.39, p=0.1, n=18), but a weak correlation between the lean mass 




The purpose of this study was to investigate the composition of the lymphedematous arm 
in terms of arm fat mass, arm lean mass, forearm strength and arm volume in women diagnosed 
with stage 2 breast cancer-related lymphedema (BCRL). Multiple comparison tests were done 
between the arm affected with lymphedema and the arm that was unaffected. The same tests were 
done on a group of healthy control women.  
 
The results of this study had two main findings:  
 
1) The presence of lymphedema is more prevalent in the mid-forearm area:  
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The most common method to assess lymphedema is arm circumference measurements using a 
tape circumference. This method allows the clinician to obtain an overall volume measurement of 
the arm, from which the overall volume of the affected arm is compared to the overall volume of 
the unaffected arm. This is then used to determine the severity of the lymphedema. In our study, 
we computed the ratio of the affected over the unaffected arm at each of the six locations and 
compared the differences amongst each of the ratios. Interestingly location 3 (mid forearm) stood 
out from locations 1 and 6, where location 3 had the highest circumference ratio difference, 
regardless of hand dominance. This means that the circumference of the arm at the level of the 
mid-forearm area was significantly different than the extremities of the arm, that is the palm and 
the shoulder and the ratio between the affected over the unaffected arm was the greatest at the 
mid-forearm level. We found that there was 14% more lymphedema present at the level of the 
mid-forearm on the affected arm compared to the unaffected arm. When looking at the palm of 
the hand, we found that the unaffected arm was only 2% smaller in terms of circumference 
compared to the affected arm. This finding correlates with the finding from the study conducted 
by Czerniec, et al. (2015), where they also found the forearm, more specifically the region 10-20 
cm away from the wrist, to contain the highest fat difference as measured by the DXA and BIS 
between the affected and unaffected arms compared to the rest of the arm.  These findings may 
suggest that lymphedema onset may start around the mid-forearm area. This location should then 
be examined in more detail and may indicate that lymphedema begins to accumulate distally to 
proximally, except for the hand and palm region. This may be explained by anatomical and 
histological features (variable tissue compliance in these regions, differences in density of 
vasculature in these regions, increased muscular motions in the hand) that may help in preventing 
the accumulation in fluid in the hand. In clinical practice, when trying to detect early onset 
lymphedema, the mid-forearm region may perhaps be the location to begin the assessment.  
 
2) Handgrip strength does not correlate with lean mass in the lymphedema arm 
 
Prior to this study we hypothesized that there would be a strong correlation between handgrip 
strength and lean mass. One would think that if an individual had increased muscle mass, they 
would score higher on the handgrip dynamometer. In fact, Raj et al (2016) assessed the strength 
of the knee extensors of 36 participants using a Biodex and correlated it to the muscle thickness 
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that was measured using an Ultrasound device. The author’s study showed significant 
correlations between the isometric and isokinetic strength of the quadriceps muscles and the 
muscle thickness. Similarly, in our control group, we found strong correlations between handgrip 
strength and lean mass. However, there was no correlation between the measurement in handgrip 
strength and the DXA measurement of lean mass in our lymphedema group. One possibility for 
this unexpected finding is that the excess fluid in the lymphedematous arm could be impeding 
muscle function and thus reduce handgrip strength. However, another possibility exists because 
lean mass as measured through the DXA includes not only muscle mass, but other tissue 
components as well. Specifically, lean tissue is defined as muscle connective tissue, fluid, 
proteins, glycogen, water and non-bone minerals. We believe that the increased fluid and 
inflammatory tissue components in lymphedema are what are causing this lack of correlation. In 
a study by Newman et al. (2013), the authors found a 15.6% more lean mass, as measured 
through a DXA, in the affected lymphedema arms of 24 women with BCRL as compared to the 
unaffected side and also suggested that the large difference between the two arms was mainly due 
to the fluid component in the lymphedematous limb. Furthermore, in our study we also found no 
such correlation between handgrip strength and lean mass in both the affected as well as the 
unaffected arm, suggesting the possibility that there may also be excess fluid in the unaffected 
arm. This may mean that the opposite limb may have a slight lymphedema as well, and that these 
women who were diagnosed with stage 2 unilateral lymphedema may in fact have a minor form 
of bilateral lymphedema. Similar questions have been raised in past research. In fact, Batse 
(2010) also suggested poor lymphatic function on the unaffected limb of women with BCRL. 
Further research would have to be done to investigate this in more detail.  In a study conducted 
by Hoffner et al. (2017), water-fat magnetic resonance imaging was used to quantify and localize 
fat and water in the limbs of seven patients with arm lymphedema and six patients with leg 
lymphedema. Measurements of the healthy limb along with the lymphedematous limb were taken 
at baseline and five different time points following surgical liposuction. The authors were able to 
identify how water and muscle volumes in lymphedema change over time following liposuction 
and noticed a decrease in subfascial water/muscle compared to baseline starting at 3 months. The 
water-fat MRI technique that was used in that study, did not differentiate between the muscle 
tissue and water. It would be interesting to assess an imaging technique that would be able to 
identify each component separately and assess the changes in fluid over time in both the 
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lymphedema arm and contralateral arm over time to see if fluid may be accumulating in the 
contralateral limb as well.  
 
In our study, we found there to be no significant difference in either lean nor fat 
measurements between the lymphedematous and the contralateral arms; however, the affected 
limb was significantly larger in volume. Here again, it leads us to think that reason for this large 
increase in volume may be related to the differences in fluid component. When looking at these 
same outcome measurements in our group of control women, these differences were not 
significant. We believe we found no significant differences in lean measurements and fat 
measurements in the lymphedema group because our sample size was small. When taking 
handedness into consideration, we did identify a significant difference when the arm affected 
with lymphedema was the non-dominant arm, where we found that it had more lean and fat tissue 
than the dominant unaffected arm. This is supported by a study conducted by Dylke et al (2013), 
where the researchers found that the volumes of fat and lean tissue are related to whether the 
affected side happens to be the dominant limb, and on the severity of the lymphedema. Using 
DXA and BIS, the authors compared the arms of 56 women diagnosed with stage 2 lymphedema 
to 44 women with no history of breast cancer and no lymphedema. The authors found there to be 
a correlation with all the tissue volumes (interlimb fat, interlimb lean and total volume) between 
the severity of the lymphedema and the side affected (fat: F=3.22, p=0.04; lean: F=10.70, 
p<0.001; total: F= 11.07, p<0.001). In order to assess the effect on limb dominance, the authors 
assessed the tissue composition first on the dominant arms of the control women and found 
significantly less fat (t=-2.90, p=0.005), but more lean tissue (t=6.9871, p<0.001) on the 
dominant arm compared to the non-dominant. When looking at the lymphedema group, the 
authors found that when the dominant arm was the affected limb, there was significantly more fat 
(t=3.694, p<0.001, but less lean tissue (-1.508, p=0.14) than the dominant arms of the control 
women without lymphedema. However, the non-dominant and unaffected lymphedema arm did 
not show significant difference when compared to the non-dominant arm of the controls (fat: 
p=0.15, lean: p=0.09, overall volume=0.89). Although this study looks at the effect of arm 
dominance on lymphedema, it uses the arm of a healthy woman as a control, and compares it to 
the affected lymphedema arm of the patient. This can lead to some limitations as it does not 
consider general variations in body composition that are possible between two different people. 
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In our study, we looked at the differences between the arms of the controls separately than the 
differences in the arms of the women with lymphedema.  We identified a trend where the 
dominant arms of the control had more lean tissue and fat tissue than their non-dominant side. 
This could be explained by the fact the dominant arm is used more often to complete general 
activities of daily living. Research has previously shown that the dominant arm of a healthy 
population has more lean tissue than the non-dominant arm (Taafe et al. 1994). In the 
experimental group, we found a significantly larger amount of arm fat and arm lean tissue when 
the non-dominant arm was the arm affected with lymphedema. Czerniec et al. (2015), also found 
similar results, where the women who had lymphedema on their non-dominant arm had greater 
differences in absolute fat mass as compared to the women whose dominant arm was affected. 
This could be explained by the fact that these women may be less likely to use or exercise their 
non-dominant arm, leading to higher fatty tissue and higher lean tissue where the fluid 
component may be affecting the lean value. We could assume that the non-dominant arm has a 
larger amount of lymphedema present (more fluid affecting the lean value, more fatty tissue 
deposits) due to the lower amount of use and movements on a non-dominant arm as compared to 
a dominant arm. It is known that exercise helps treat and prevent lymphedema (Park et al. 2008, 
Johansson et al. 2002).  
 
We also compared the tissue composition of the two limbs of both groups using ratios of the 
affected over the unaffected arms of the BCRL group and right over left arms of the healthy 
control women for measurements of arm fat and arm lean. When looking at the ratio between the 
affected and unaffected arm, we found there to be larger fat and lean composition in the affected 
arms compared to the unaffected arms. There was also a similar but much smaller difference in 
the right arm, or in this case the dominant limb of the control women compared to the left arm. 
The difference found in the lymphedema group was significantly larger than that found in the 
control group. These results are similar to the findings by Czernec et al (2015) where they also 
found there to be significantly more fat mass and lean tissue, as measured through a DXA, in the 







In this study, we assessed the tissue composition of the arms of women diagnosed with 
breast cancer-related lymphedema in order to obtain a better understanding of the structural 
lymphedematous changes. We compared the affected arms to the opposite unaffected limbs of the 
women with lymphedema and completed the same tests on a group of healthy controls. To our 
knowledge, no other study has used such a comparison with both groups of women. This study 
has led us to believe that the swelling and structural changes caused by lymphedema following 
breast cancer seem to mainly involve the mid-forearm region of the arm. Handgrip strength was 
found not to correlate with lean mass in lymphedema patients in both the affected and unaffected 
arm, a finding thought secondary to the fact that lean mass calculation by DXA is increased by 
the excess fluid in lymphedema.  This study has also raised another new interesting hypothesises 
about the spread of the fluid accumulation in the affected arm towards the unaffected side. The 
data presented in this study is pilot data and it has raised multiple new questions regarding this 
condition. In future studies, we would like to re-assess these changes and address new questions 
regarding the fluid changes in the arm using other modalities such as ultrasound on a larger 


















Tissue Strain in a Cohort of Stage 2 Breast 










Background: Classic ultrasonography has recently emerged as a potential tool to diagnose and 
assess the treatment outcomes in patients with lymphedema, but clinicians still rely on subjective 
measurement techniques such as palpation to determine fluid accumulation in the 
lymphedematous limb. Recent advancements in ultrasound elastography show promising results 
in evaluating body composition changes and have shown to provide more quantifiable 
information on tissue elasticity or strain. The purpose of this study was to assess the muscle, fat 
and skin strain in women diagnosed with breast cancer-related stage 2 lymphedema. Methods: A 
total of 20 women with unilateral stage 2 breast-cancer related lymphedema were recruited to 
participate in this study. Patients underwent measurements of fat and lean tissue through a DXA 
scan, volume measures through a Perometer, and 7 of them were randomly selected to undergo 
strain measures through Ultrasound.  Ultrasound elastography measures were taken on both the 
affected and unaffected limb at six different landmarks along the length of the arm. Results: 
When comparing the affected and unaffected limbs through DXA or Perometer, no significant 
differences were found. There was; however, a significantly higher strain in the unaffected arm in 
terms of skin strain (0.405+0.185 vs. 0.577+0.176, p=0.01), fat strain (0.396+0.156 vs. 
0.525+0.134, p=0.01) and muscle strain (0.402+0.138 vs. 0.540+0.069, p=0.009) all at the mid-
distal arm. Furthermore, the Tukey-Kramer multiple comparison test showed that the effect of 
less compressibility and harder tissue on the affected limb was greater in the distal arm than the 
proximal arm (p=0.05), by having lower fat and muscle strain values. Conclusion: Ultrasound 
elastography could provide additional information in tissue elasticity that cannot be detected by 
other measurement techniques and potentially be useful in understanding the pathogenesis of the 




With the recent interest in ultrasonography as a tool for body composition, novel 
ultrasound techniques have been developed to assess tissue elastic properties.  Ultrasound 
elastography can be defined as an imaging method that measures the elasticity of compliant tissue 
(Cespedes et al. 1993).  It is a technique that measures the tissue deformation by compressing and 
decompressing it and has been shown to differentiate between hard and soft tissues (Adriaenssens 
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et al. 2012). In fact, pressure, produced by physiological motions, pulsation of blood vessels or 
external mechanical compressions on the tissue, produces strain and displacement within the 
tissue. This tissue deformation is then detected by pulse-echo ultrasound (Brandenburg et al. 
2014). The returning echoes are analyzed before being converted into a B-mode image (Park et 
al. 2011) and provide a measurement known as strain. The strain is smaller in harder tissues. It is 
by measuring this strain distribution that the tissue hardness can be estimated and can be used for 
disease diagnosis.  In fact, real time sonoelastography has been used for tumor detection and 
differentiation between benign and malignant lesions. It is based on the principle that tissue 
hardness is related to pathologies (Park et al. 2011). Ultrasound elastography is becoming a 
promising tool for determining the material and mechanical properties of tissues and has been 
applied in multiple clinical settings, for example in the assessment of various musculoskeletal 
disorders such as congenital muscular torticollis, early detection of osteoarthritis, peripheral 
nerve lesions and myopathies (Park et al. 2011). The technique also shows promising results in 
predicting muscle response to treatment and monitoring muscle responses to clinical 
interventions (Brandenburg et al. 2014).    
 
Although ultrasound has only recently begun to be researched in the diagnosis and staging 
of breast cancer-related lymphedema, preliminary results are shown to be valid and reliable (Li et 
al. 2012). Further research is needed to investigate the use of elastography as a way to 
specifically quantify the staging of lymphedema based on the body composition of the upper 
extremity following breast cancer treatment. The first step in this process remains to gain an 
understanding in the different structural changes that occur in the limb affected by lymphedema 
and how this compares to an unaffected limb. Lymphedema patients are usually diagnosed in the 
late phase of stage 1 or early phase of stage 2. This is the point where the disease may still be 
reversible. It is towards the end of stage 2 that the disease becomes chronic and controlling its 
progression becomes the only treatment option.  Stage 2 lymphedema is characterized by tissue 
changes, including the initial development of fibrosis and the deposition of adipose tissue (Dixon 
et al. 2015).  In current clinical practice, the most common methods used to diagnose and stage 
the condition is based on subjective palpation and pitting tests to assess the hardening, elasticity 
and fluid content of the tissue, as well volumetric measurement techniques such as 
circumferential tape measurements and Perometer volume measures. These methods all fail to 
 49
provide objective quantifiable data on the underlying tissue characteristics, and as a result the 
condition tends to lead to a late diagnosis of lymphedema that is past the point of reversibility 
(Dixon et al 2015). 
 
Given the current state of the clinical art in assessing and staging lymphedema and the 
lack of any reliable objective method that can be used repeatedly in a safe and economic manner, 
we proposed in this study to use ultrasound, more specifically ultrasound quantitative techniques 
such as elastography to assess the elasticity of lymphedematous arms in order to obtain additional 
knowledge on the tissue changes that occur in stage 2 lymphedema. In particular, we wished to 
assess tissue thicknesses (e.g., skin, subcutaneous layers and skeletal muscles), as well as the 






A total of 20 women diagnosed with breast cancer-related lymphedema were included in this 
study. Our main purpose was to provide pilot data for a new area of research. The study was an 




The inclusion criteria consisted of women diagnosed with stage 2 unilateral lymphedema 
following breast cancer treatment. Patients that demonstrated the following criteria were 
approached to participate in this study: 
• Age 18 years or over 
• BMI of 25 or over 
• Diagnosis of unilateral stage 2 lymphedema  
• Fluent in English or French, or accompanied by someone who is fluent in English or 
French 
We chose to include a BMI of 25 or over as a higher BMI is an increased risk factor for 
lymphedema (Garza et al. 2017) and most patients fall into this category.  
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Exclusion Criteria 
  The following exclusion criteria was applied:  
• Diagnosis of recurrent cancer  
• Currently under treatment for breast cancer 
• Bilateral lymphedema of the arms  
• Any diagnosis of the following diseases: heart, liver, or kidney disease 
 
All the women who participated in the study were recruited from the McGill University 
Health Centre (MUHC) Lymphedema Program and the MUHC Cedars Breast Centre. A total of 
20 women agreed to participate in a larger study. Due to time and financial restraints, we 
collected additional ultrasound data on 7 women. The seven women were randomly selected, by 




Procedures were carried out at the McGill Nutrition and Performance Laboratory. 
Procedures and assessments were explained and informed consent was obtained. Participants age, 
date of birth and medical history were recorded, followed by the measurement of their height and 
weight from which BMI was then calculated. The weight scale used in this study was a Detecto 
Scale Model 750 (+/- 0.1kg). The tool we used to measure the participants’ height was a Seca 
Wall Mounted Height Scale (+/- 0.1cm).  
 
Those who underwent ultrasound measurements, were asked to sit on a chair with both 
feet flat on the floor and their back rested on the chair. The measurements were taken on both 
arms, with the arm that was being assessed resting straight on a table at the level of the heart and 
the palm of the hand facing up. The researcher was sitting on a stool in front of the participant. 
Landmarks were taken at 6 different locations along both arms. The researcher started by 
marking the landmarks on the participants arm using a crayon and a 100-cm long cloth tape 
measure (+/- 0.1cm). The following six landmarks were identified:  
1- 20% of the distance between the 5
th
 digit to the styloid process of the wrist 
2- 20% of the distance between the styloid process to the tip of the olecranon  
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placed by their side with their hands stacked and fingers together. All jewelry was instructed to 
be removed for the scan. The scan took a total of 6 minutes.  
 
In addition, patients underwent measurements with the perometer Pero System Type 350 NT 
(Peroplus 2000 built 2014.01h). The peromoter was used once on each arm. Patients were asked 
to sit with their legs uncrossed, with their feet on the floor at a 90-degree angle. The perometer 
was then adjusted accordingly to the patient’s height such that their arm was able to extend at a 
90-degree angle, in an abducted position with the palm facing down and with the tip of the 
middle finger resting on the appropriate location of the machine. The machine was then moved 
along the length of the patient’s arm to grasp a volume measure of the entire arm.  
 
Handgrip strength measurements were also collected. The subjects were seated with their 
back rested and forearm placed at a 90-degree angle on the chair’s arm rest. Subjects were asked 
to squeeze the handgrip dynamometer (Jamar Hydraulic Hand Dynamometer +/- 0.1 kg) as hard 
as they can for a total of 2 seconds. The handgrip test was repeated twice, alternating both arms. 
Only the strongest value was recorded for this study.  
 
3. Statistical Analyses  
 
Demographic data was compared between the 7 randomly chosen subjects and the entire 
group of 20 women using mean + standard deviation and independent t tests. Measurements of 
tissue strain were recorded from the ultrasound scans. Tissue strain included muscle strain, skin 
strain and fat strain. All these measurements were calculated using MATLAB. The ultrasound gel 
pad was used as standard elasticity. Prior to completing any of these calculations the elasticity of 
the gel pad alone was measured using a CIRS phantom. All strain calculations were measured by 
our trained computer engineer on the research team. Tissue strain measurements of the arm 
affected with lymphedema was compared to the arm without lymphedema at each of the 6 
locations, using paired t-tests. A series of strain ratios comparing the affected over the unaffected 
arm for each tissue over the 6 locations was also completed. A One-Way ANOVA followed by a 
Tukey-Kramer multiple comparison test were used to determine if there were any differences in 
muscle strain, fat strain and skin strain along the length of the arm.  
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4. Ethics and Funding 
 
Ethics approval was obtained from the McGill University Health Centre and Concordia 
University. We obtained funding for this study from the Dr. Louis G. Johnson Foundation 




Ultrasound data was collected from 20 women diagnosed with breast cancer-related 
lymphedema; of which 7 were randomly selected and calculations of fat strain, muscle strain and 
skin strain were obtained.  The 7 randomly selected subjects were representative of the group of 
twenty as demonstrated by demographic data (see table 1). Although the cohort of 7 women had 
an older mean age and a slightly lower BMI, these differences were not significant (p>0.05). One 
participant refused to do the DXA scan, as a result she was excluded from the DXA analyses.  
 
TABLE 1: Comparisons between the cohort of 20 women recruited in this study and the 7 
randomly selected women that were analyzed  
 





Age  56 + 14.8 65.3 + 10.5 0.143 
Height (m) 1.62 + 0.07 1.61+ 0.087 0.698 
Weight (kg) 84.6 + 18.4 81.1 + 24.2 0.752 
BMI (kg/m2) 32.1 + 7.2 30.9 + 8.4 0.726 
Body Fat (%) 47.5 47.5 0.996 
Total fat (Kg) 39.1 38.1 0.885 
Total lean (Kg) 41.6 39.6 0.484 
 
1. Comparing affected to unaffected arm 
 
 The arm affected with lymphedema was compared to the opposite arm, using the 
unaffected arm as a control. Both arms were compared in terms of arm volume, handgrip 
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strength, arm fat and arm lean. There were no significant differences between the affected arm 
compared to the unaffected arm. The results are summarized in table 2:  
 
TABLE 2: General comparisons between the affected lymphedema arm and the unaffected arm 
 
 Affected Arm + SD Unaffected Arm + SD Paired t-test  
Perometer (mL) 3655 + 849 3278 + 1327 0.162 
Grip Strength (Kg) 20.57 + 9.57 22 + 5.99 0.735 
DXA Arm fat 
(Kg) 
1.59 + 0.817 2.324 + 2.288 0.378 
DXA Arm Lean 
(Kg) 
1.830 + 0.430 1.95 +0.714 0.778 
 
Comparisons in arm strain measurements were assessed between both arms. Strain 
measurements in terms of skin, fat and muscle were obtained at each of the 6 locations along 
each limb. Paired t-tests were used to compare the strain value of each location on the affected 
arm to the unaffected arm. Skin strain on the affected limb was significantly different to the 
unaffected limb at locations 1, 2, and 3. Fat strain on the affected limb was significantly different 
to the unaffected limb at locations 1, 3, 4 and 5. A trend was noted at locations 2 and 6. Muscle 
strain on the affected arm was significantly different then the unaffected arm at locations 1, 2, 4, 
and 5. A trend was identified at location 6. Results are summarized in table 3. The affected arm 








TABLE 3: Comparisons of the affected and unaffected tissue strain measurements for skin, fat 
and muscle  
Tissue  Location Affected  Unaffected  Paired t-tests  
Skin  1 0.405 + 0.185 0.577 + 0.176 0.001 * 
2 0.302 + 0.158 0.465 + 0.194 0.046 * 
3 0.317 + 0.131 0.666 + 0.386 0.049 * 
4 0.396 + 0.218 0.467 + 0.160 0.367 
5 0.405 + 0.225 0.557 + 0.208 0.179 
6 0.54 + 0.301 0.738 + 0.312 0.101 
Fat  1 0.396 + 0.156 0.525 + 0.134 0.011* 
2 0.238 + 0.131 0.605 + 0.498 0.083 (trend) 
3 0.228 + 0.053 0.488+ 0.207 0.009* 
4 0.368 + 0.222 0.579 + 0.243 0.012* 
5 0.496 + 0.314 0.957 + 0.296 0.004* 
6 0.724 + 0.583 1.43 + 0.759 0.062 (trend) 
Muscle  1 0.402 +0.138 0.540+0.069 0.009 * 
2 0.316+0.174 0.634+0.260 0.007* 
3 0.584+0.550 0.880+0.270 0.185 
4 0.655+0.376 1.165+0.636 0.019* 
5 0.695+0.395 1.329+0.487 0.007* 
6 0.877+0.226 1.585+0.835 0.091 (trend) 
 
 
2. Comparing different locations along the arm 
 
The strain values along the 6 locations of each arm were also compared. A one-way 
analysis of variance was used to compare the 6 different locations along the length of the arm 
affected with lymphedema. The same was then done on the unaffected arm. There were no 
significant differences along the length of the arm and across the 6 different locations in terms of 
skin strain measurements on both the affected and unaffected arms.  
 
In terms of fat strain, differences were identified across the 6 locations in both the 
affected and the unaffected arms. The Tukey-Kramer multiple comparison test showed that the 
strain on the affected arm was lower in location 2 and location 3 compared to location 6 (p<0.05), 
meaning the distal locations 2 and 3 have less compressibility and harder tissue compared to the 
proximal location 6 (figure 2a).	When looking at the unaffected arm, differences in fat strain were 
also seen. The Tukey post Hoc test showed that location 6 was significantly higher than locations 
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1, 2, 3, and 4 (p<0.05). Differences across the 6 locations along the length of the arm were also 
seen in terms of muscle strain. According to the Tukey post hoc test, location 6 was shown to be 
significantly greater than location 2 on the affected arm (p<0.05), as shown on figure 2b. On the 
unaffected arm, location 6 was shown to be significantly larger when compared to location 1 and 
location 2 (p=0.05).  
 
FIGURE 2: (A) Fat strain differences found across the 6 landmarks along the affected and 
unaffected arms. (B) Muscle strain differences found across the same 6 landmarks along the 

















































3. Comparing strain ratios of affected over unaffected arm 
 
A ratio of the affected over the unaffected arm in terms of skin strain, fat strain and 
muscle strain at all 6 locations was computed. Comparisons were then using a one-way ANOVA.   
 
Overall the skin strain ratio had 28% less strain on the affected lymphedema arm 
compared to the unaffected side (mean skin strain ratio: 0.724). This strain was consistent 
throughout the affected arm as evidenced by the lack of any strain differences among the 6 
different locations (range: 0.581-0.854). A lesser strain represents less compressibility and harder 
tissue in the affected arm. 
 
Overall the fat strain ratio was 41% less strain on the affected arm compared to on the 
unaffected arm (mean fat strain ratio: 0.585). This strain was also consistent throughout the 
affected arm as evidenced by the lack of any strain differences among the 6 different locations 
(range: 0.502-0.745). 
 
Overall there was a 37% less strain skeletal muscle on the affected arm, compared to on 
the unaffected arm (mean skeletal muscle strain: 0.63). This strain was also consistent throughout 
the affected arm as evidenced by the lack of any strain differences among the 6 different 
locations (range:0.531-0.734). 
 
4. Global mean differences in skin, fat and muscle tissue 
 
 The final part of the study was to assess the global mean differences in skin, fat and 
muscle tissue of all 7 subjects across the 6 different locations, using a paired t-test.  The mean 
skin strain ratio of the affected arm (0.395 + 0.212) was found to be significantly lower than that 
of the unaffected arm (0.592 + 0.268), p=0.000029, n=42. The mean fat strain ratio of the 
affected arm (0.409 + 0.327) was found to be significantly lower than that of the unaffected arm 
(0.764 + 0.516), p=0.031, n=42. The mean muscle strain ratio of the affected arm (0.544 + 0.329) 
was significantly lower than that of the unaffected arm (1.023 + 0.6000), p=0.00002, n=42. 
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Overall, the strain of the affected arm (0.449 +0.300) was significantly lower than that of the 
unaffected arm (0.777+0.486), p=0.000001, n=42, consistent with the less compressible, harder 




The purpose of this study was to assess the tissue strain measurements of the arms of 
women diagnosed with lymphedema following breast cancer surgery using ultrasound 
elastography. The data collected consisted of pilot data in order to observe the underlying 
differences in skin strain, fat strain and muscle strain in the affected lymphedematous arm as 
compared to the unaffected side.  
We found there to be multiple differences in all three strain types between both arms. For 
all three strain measurements, there is a noted decrease in strain or compressibility in the distal 
affected limb when compared to the unaffected limb. These structural changes align the those 
seen in the previous research in chapter 2 where there were noticeable differences of 
lymphedematous properties in the mid-forearm region.  
 
In this study, we found overall differences in strain ratios between both arms where there 
was less skin strain and fat strain on the affected arm and less muscle strain on the affected arm 
suggesting that lymphedema decreases tissue compliance. This could be explained by the fact the 
women may be less inclined to use their arm affected with lymphedema due to the symptoms of 
heaviness and discomfort felt from the pathology and therefore lead to muscle atrophy on the 
affected side. The increase in fat deposits on the lymphedematous limb from the damage to the 
lymphatic system could also explain the differences found in the fat strain. These are novel 
findings. As to our knowledge, there have been no studies that have investigated the strain 
compositions of the different tissue components in patients with lymphedema. Most studies in the 
lymphedema population that use ultrasound focus on the changes in thickness of the dermis and 
subcutis area of the skin using classic B-mode ultrasound (Hacard et al. 2013, Suehiro et al. 2015, 
Bok et al. 2016). B-mode ultrasound could pose difficulties with spatial resolution (Tassenoy et 
al. 2016). It has been previously shown that ultrasound elastography has the ability to better 
detect tumors and cysts than classic B-mode ultrasonography (Hall et al. 2003).  
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Although there have been some studies that used ultrasound elastography on lymphedema 
patients, none of them to our knowledge, assessed the differences between the affected and 
unaffected sides of lymphedema showing the potential changes that could occur in the terms of 
the tissue structures from the pathology. The main studies involving lymphedema patients that 
focused on elastography were used to either detect the pathology or to compare the technique to 
other ultrasound techniques. In a study conducted by Righetti et al (2007) poroelastography was 
assessed as a tool to detect lymphedema. Poroelastography is defined as a type of elastography in 
which a time sequence is obtained from a poroelastic material under compression and may 
provide information on the permeability of the material (Righetti et al. 2005). A poroelastogram 
represents the images of the change in Poisson ratio over time, in which the Poisson ratio is 
defined as the ratio between the lateral to axial strain when a downward compression is applied to 
an elastic material. The rate of change in the Poisson ratio may provide information on the 
movement of fluid within the tissue (Park et al. 2011). In their study, Righetti et al. (2007) 
investigated seven females and one male with lymphedema, along with five females without 
lymphedema. Poroelastographic images were taken on the thighs and forearms of each 
individual.  The authors used a 7.5 MHz array transducer and a 20 MHz sampling frequency. The 
authors hypothesized that lymphedematous tissue could be classified according to their 
poroelastic materials based on the tissue properties. The authors described the tissue as a coupled 
phenomenon composed of a solid matrix deformation and a fluid translocation. Based on the 
tissue elastic properties, the compressibility of the tissue and the porosity of the matrix, the 
poroelastograms could be used to distinguish lymphedematous tissue from normal tissue.  
 
 In another study conducted by Adriaenssens et al (2012), ultrasound elastography was 
compared to high frequency ultrasound. Data was collected from twenty women with breast 
edema following breast cancer surgery from the University Hospital of Brussels.  The authors 
assessed both breasts before and after the breast cancer surgery and tested whether ultrasound 
elastography can quantitatively measure early breast edema following breast cancer surgery and 
irradiation as compared to the untreated breast. Measurements were performed on both breasts 
and on four different quadrants defined as the upper inner quadrant, lower inner quadrant, lower 
outer quadrant and upper outer quadrant. For the elastography measures, the ultrasound 
transducer was compressed five times onto the skin. The elastogram displayed both a strain color 
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image, comparing the strain values of tissues with different elasticity, and a strain graph. Using a 
standardized region of interest box, ratios were calculated on all quadrants of the breast. The 
authors used a 12MHz linear transducer for both the high frequency ultrasound technique and the 
elastography method. The authors assessed multiple outcomes using a 4-point categorical 
questionnaire and the above-mentioned ultrasound techniques. The authors identified an increase 
in subjective swelling, an increase in mean skin thickness an increase in the mean echogenicity 
on the lymphedematous breast. The authors also found significant increase in interstitial fluid 
following breast cancer surgery. The authors also stated that ultrasound elastography was 
significantly correlated with the visibility of the echogenic line as measured from the high 
frequency ultrasound. It was therefore concluded that ultrasound elastography could be an 
objective tool for early diagnosis of breast edema. Although these two studies provided additional 
knowledge and insight to detect lymphedema, they failed to provide any additional details on 
structural tissue components that result from lymphedema.  
 
Johnson et al (2015) assessed lymphedema using ultrasound. The authors measured the 
tissue texture by using entropy (a measure of randomness within the ultrasound image 
representing the organization of the tissue) and average pixel intensity (reflecting the brightness 
or echogenicity of the structure) as variables. The authors tested the correlations of the ultrasound 
measures compared to the physiotherapists’ clinical assessments and also compared the 
ultrasound image data of the affected lymphedematous arm to the unaffected arm. Ultrasound 
entropy measures showed a significant difference between the affected (mean=6.09; CI: 5.98-
6.21) and unaffected arms (mean=6.17; CI: 6.05-6.28), p=0.03. Entropy measures also correlated 
well with the patient’s self-reporting of edema and fibrosis at the lateral elbow (Spearman’s rho=-
0.35; p=0.05). The authors therefore concluded ultrasound to be a promising tool to measure 
lymphedema tissue texture in a safe and effective manner. Again, this study did not provide any 
information on the different tissue components in the lymphedematous limb.  
 
There have been studies that have assessed structural compositions in a healthy cohort, 
such as in the study conducted by Hwang et al (2014), where the soft tissue thickness was 
measured through ultrasound in the arms of 20 healthy women and was compared to perometry 
volume measures. Circumference measures were taken at 10 cm above and below the elbow 
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crease by two different examiners and on sixteen different sites using a tape measure. The 
amount of soft tissue was found using a transducer with a frequency of 7.5 MHz and the soft-
tissue thickness was measured from the distance between the skin and the fascia of the muscle. 
The cross-sectional area of the tissue was then calculated. The authors found the use ultrasound 
as a measure of soft tissue thickness to have a strong intra-rater and inter-rater reliability. The 
study also showed strong correlation coefficients between ultrasound and perometry. The authors 
also found strong correlations between the cross-sectional area measures and circumference 
measures above the elbow. The authors concluded that ultrasonography could be an alternate way 
to measure the status of soft tissue. They identified multiple advantages to this technique. In fact, 
they described ultrasound as a safe technique that can be used repeatedly and efficiently. 
Furthermore, they suggested that using cross-sectional measurement from ultrasound gives an 
adequate volume measure. Finally, the authors suggested that this method allows observations of 
structural and tissue property changes in a cost-effective manner, as opposed to the traditional 
measures of perometry and tape measuring that do not take tissue structure or properties in 
consideration and as compared to expensive methods such as MRI and CT. The main limitation 
that was stated in this technique was that the volume measure taken from the ultrasound was an 
indirect measure, as they were unable to directly measure the entire limb.  
 
In our study, we found there to be no significant differences between affected and 
unaffected arms of the women with lymphedema in terms of volume, handgrip strength, arm fat 
and arm lean when measured through the Perometer, handgrip strength and DXA. When looking 
at measurements taken via ultrasound elastography we found significant differences between the 
two arms. Ultrasound elastography is therefore a more sensitive tool that could provide additional 
quantitative and qualitative data on the structural components of the arm and is a safe and 
efficient technique that could potentially be used for early detection of breast cancer related 
lymphedema, as well as to assess and follow women who have been previously diagnosed with 
BCRL. Furthermore, the high definition of the strain elastography technique may be helpful to 
identify those who have more inflammatory and quickly progressive lymphedema, and therefore 
may need more attention and more frequent follow-ups with therapists. These results may also 
aid in the early diagnosis of patients who may have signs of malignant lymphedema as an early 
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sign of recurrent cancer. Malignant lymphedema not only progresses more quickly, but also 




These preliminary findings suggest that ultrasound elastography is a technique that could 
be used to assess the tissue changes in the arms of women who have been diagnosed with breast 
cancer-related lymphedema, as it provides additional information on the tissue strain (fat, muscle 
and skin) that you would not get from other techniques that are currently used to monitor and 
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Lymphedema of the upper extremity is a condition negatively affecting the quality of life 
of many women who are breast cancer survivors. This chronic condition currently has no cure 
and research has described it to be as stressful as the initial diagnosis of breast cancer as well as a 
continuous reminder of the cancer (Park et al. 2008).  Indeed, the swelling and complications 
caused by the damage to the lymphatic system lead to negative changes on the patient’s self-
image on top of the impact many already obtained from the mastectomy itself.  In addition to the 
psychological and psychosocial burden, the patient also feels physical symptoms, such as pain, 
heaviness and numbness, for the remainder of their life.  
  
The lack of standardization in diagnosing the condition and the lack of information about 
the various tissue changes that occur as a result of the condition, create multiple challenges in 
treating and monitoring the improvements or progression of the lymphedema. First, tissue 
changes of lymphedema occur much sooner than any visible swelling, causing clinicians to often 
diagnose the condition passed the point of possible reversibility and focusing treatment on 
maintenance. The reasons for this are numerous. In addition, there exist no standard defined 
criteria that stage the severity of the lymphedema that are agreed upon by researchers and 
clinicians. Furthermore, the currently used techniques to assess lymphedema are subjective and 
provide no information on the underlying tissue changes occurring beneath the skin. Indeed, the 
most common methods used include circumferential tape measurements and palpation. 
Circumferential tape measures provide information on the area and volume changes of the arm, 
but no information on whether these changes are due to alterations in fluid or blood flow, adipose 
tissue changes, or muscle atrophy or hypertrophy. Palpation is used to evaluate the edema and 
further stage the severity of the condition based on pitting, that is the ability of the tissue to 
bounce back after pushing down on the skin.  
 
There is very little research done on lymphedema and a large gap as to understanding, 
diagnosing and monitoring the condition. Most studies focus on measuring the success of 
treatments such as decongestive or compression therapy on patients who have been diagnosed 
with the condition using relatively subjective techniques such as circumference measures. More 
recent studies have begun to use ultrasonography as a measurement tool to diagnose the condition 
or monitor treatment outcomes, and these early results suggest that tool is valid and reliable (Li et 
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al. 2012). However, these results are preliminary, and fail to compare the affected lymphedema 
side to the unaffected side or to compare to a group of healthy controls.  This thesis project was 
therefore divided into two parts; (1) gaining an overall understanding of the underlying tissue 
changes in the affected lymphedema limb and how this compares to the opposite unaffected side 
(2) obtaining measures of tissue strain through novel ultrasound elastography to detect 
lymphedema and understand the effect of lymphedema on different tissue components (eg. fat, 
skin and muscle).  
 
In the first study, we used multiple techniques including DXA, Perometer, arm 
circumference measurement techniques and handgrip strength to observe the changes in lean 
tissue, fat tissue, volume and strength. Interestingly, we found a significantly larger concentration 
of lymphedema around the mid-forearm area. This difference remained when controlling for the 
patients’ dominant hand. The palm area was also found to have the smallest circumference ratio 
in the lymphedematous arm. This finding suggests that the onset of lymphedema may begin to 
form around the mid-forearm area and further spread proximally, apart from the hand. We 
believe there are protective anatomical factors regarding the early development of the 
lymphedema in the hand such as the fascia, or blood vessels, or perhaps the more frequent hand 
movements propel the fluid more proximally. Another of our interesting and this time surprising 
finding is the lack of correlation between handgrip strength and lean mass in the women 
diagnosed with lymphedema, as opposed to the strong correlation we found in the control group. 
We believe the difference between the two groups is due to the fact that lean tissue as measured 
by DXA is composed not only of muscle mass, but also includes fluids, minerals and proteins, 
and that the fluids may be falsely raising the DXA measured estimate of muscle mass. The study 
also raised a question as to whether excess fluid might also begin to develop in the unaffected 
side.  
 
These novel findings open multiple areas of new research regarding the pathogenesis of 
lymphedema, the spread of lymphedema and could also provide additional information about 
early diagnosis (given earlier findings in the mid-forearm) and which can potentially lead to 
identifying the best treatment alternative for the patient. These results are pilot data, stemming 
from a small cohort of women. Future research is needed to assess each of these questions in 
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more detail, with a larger number of patients, and by controlling for additional variables, that we 
did not take into consideration in this study, such as age, a narrower BMI window, and the type 
of breast-cancer treatment that the patient underwent.  
 
The second study was focused specifically on the use of ultrasound elastography to 
observe the elasticity, or strain of the different tissue compositions in the lymphedematous limb 
in order to provide additional insight and details on the changes occurring in the affected limb. To 
our knowledge no such study has been conducted in this type of population. First, we established 
a novel elastography method that focused on better time delay estimation and better quality of 
displacement estimation by using a second-order derivative and reliably estimated strain images 
(Hashemi et al. 2019). We then used this method in patients with unilateral breast-cancer related 
lymphedema at stage 2 to compare the affected arm to the unaffected arm. The results showed 
promising findings in terms of using this tool to assess the condition. We found differences in 
skin strain, fat strain and muscle strain between both the affected limb and the unaffected limb, 
where there was significantly lower strain in the affected arm, meaning the tissue was harder, and 
less compressible the healthy limb, and these differences were more prominent in the lower-
forearm region, which aligns with the findings from the DXA from the first part of the study. 
Both studies suggest that this area may be the area first affected by lymphedema as this area has 
the largest circumference ratio and smallest strain values than the rest of the arm, meaning that 
the changes are occurring at a faster rate in that region. Again, this data was strictly for 
observational purposes and provided pilot data.  Limitations of the study include the small 
sample size, and the lack of a comparison to a group of healthy controls. We did; however, try to 
factor in these limitations, by using the healthy unaffected arm of women with unilateral 
lymphedema to act as a control limb, and the cohort of 7 women used in this study were 
representative of the larger cohort of 20 women that were recruited, when examined for 
differences in age, height, weight, BMI, and body composition (body fat%, lean mass, and fat 
mass). 
 
Overall, this project presented multiple novel findings in the area of breast cancer-related 
lymphedema and raised multiple questions regarding the onset of lymphedema, the spread of 
lymphedema and the possibility of the condition spreading to involve other regions. Furthermore, 
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it provided positive and promising results regarding the use of the more objective ultrasound tool 
to be used as method to diagnose, assess and monitor lymphedema as opposed to the classic 
subjective techniques that are currently used in this field. Ultrasonography has proven to be 
useful in providing more quantifiable data, is quick, easy to use, portable and more affordable 
that other available technologies.  Future studies focusing on reliability and reproducibility of this 
tool in a larger sample of population are required, along with studies comparing both a group of 
women affected by condition as well as a group of healthy controls. It would also be interesting 
to study the correlations of volume segments along the arm and to see if they correlate with the 
strain measurements taken from the ultrasound elastography, especially in terms of the 
differences that were identified in the mid-forearm regions. Clinical observations have also 
suggested possible early manifestation of lymphedema right above the elbow (personal 
communication, Dr. Anna Towers, March 2019). It would be interesting to study that region in 
additional detail along with the mid-forearm region and to complete a longitudinal study using 
ultrasound elastography, where we would follow patients from their initial breast cancer 
treatment in order to see the changes in strain over time. As research progresses in this domain, 
we will gain a larger overall understanding of lymphedema, be able to stage the patients based on 
severity, be better able to follow disease progression, and substantially determine the best 
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